The USP Drug Classification (USP DC) is an independent drug classification system intended for use by any stakeholder interested in a classification of drugs for use in formulary development or review in non-acute or outpatient care settings. USP DC is not intended to replace the final review provided by the local pharmacy and therapeutics (P&T) committees.

The classification system can be used for formulary support including but not limited to:
•    Building and mapping formularies
•    Reviewing formulary adequacy for a minimum baseline of drugs
•    Identifying drugs in a particular pharmacologic grouping
•    Reviewing formularies and comparing formulary design and benefits

The USP Drug Classification 2023 was published December 16, 2022. 

Instructions:

1. Complete and submit the information on the form below. Please note: (*) indicates required fields.
2. An e-mail containing the USP DC and Alignment files will be sent after submission. 

We encourage you to provide your feedback on how you use the USP DC and/or the Alignment File, and how we can improve it at uspdc@usp.org.